Machine Learning-Based Prognostic Prediction Models in Calcium Channel Blockers Poisoning

Babak Mostafazadeh1, Sayed Masoud Hosseini1, Shahin Shadnia1

  • 1Toxicological Research Center, Excellence Center of Clinical Toxicology, Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Machine learning models accurately predict outcomes for calcium channel blocker (CCB) poisoning. XGBoost and CatBoost showed superior performance, aiding early risk stratification for CCB poisoning patients.

Area of Science:

  • Toxicology
  • Medical Informatics
  • Cardiovascular Medicine

Background:

  • Calcium channel blocker (CCB) poisoning presents a significant toxicological emergency with severe cardiovascular complications.
  • Accurate prediction of CCB poisoning outcomes is crucial for timely and effective patient management.

Purpose of the Study:

  • To evaluate the accuracy of various machine learning (ML) models in predicting outcomes of CCB poisoning.
  • To identify key prognostic factors associated with CCB poisoning using ML techniques.

Main Methods:

  • A retrospective cross-sectional study of 274 CCB poisoning cases (2019-2024).
  • Trained ML models (XGBoost, CatBoost, Random Forest, AdaBoost) on clinical and laboratory data.
  • Utilized feature selection to identify 18 prognostic factors and assessed model performance using AUC, accuracy, precision, recall, and F1-score.

Main Results:

  • Feature selection identified 18 key prognostic factors, including temperature, GCS-eye response, ECG findings, and various lab values.
  • XGBoost and CatBoost achieved the highest predictive performance with macro-averaged AUC values of 0.9899 and 0.9983, respectively.
  • These ML models outperformed traditional statistical methods in risk stratification for CCB poisoning.

Conclusions:

  • ML models, particularly XGBoost and CatBoost, demonstrate high accuracy in predicting CCB poisoning outcomes.
  • These models offer a valuable data-driven framework for early risk stratification in clinical settings.
  • Future research should focus on multi-center validation and integration into clinical decision support systems.
Abstract

Related Concept Videos

Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
309
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.5K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K